Poland· PL-100416134

Kwikaton

A vildagliptin product containing vildagliptinum, registered in Poland by STADA Arzneimittel AG. The same ATC class is registered in 16 of our 19 countries.

ATC A10BH02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about vildagliptinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Vildagliptin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search vildagliptin products by name

Vildagliptin · ATC A10BH02

16 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vildagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Vildagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

CH Switzerland$1.98
IT Italy$1.0
FR France$0.32

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Vildagliptinum
Manufacturer: STADA Arzneimittel AG
Country: Poland (PL)
ATC code: A10BH02
ATC class: Vildagliptin
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 18

2 priced

gtin
05909991457556
28 szt.
PLN 15.93
gtin
05909991457570
56 szt.
PLN 30.13
gtin
05909991457549
gtin
05909991457587
gtin
05909991457594
gtin
05909991457600
gtin
05909991457617
gtin
05909991457624
gtin
05909991457631
gtin
05909991457648
gtin
05909991457655
gtin
05909991457662
gtin
05909991457679
gtin
05909991457686
gtin
05909991457693
gtin
05909991457709
gtin
05909991457716
gtin
05909991457563

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vildagliptin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vildagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Melkart, Saxotin
Belgium · Vildagliptin Krka
Bulgaria · Глипвило, Далмевин
Cyprus · Aglimon, Dalmevin
Czechia · Alikval, Anvildis
Germany · Vildabetes, Vildagliptin Al
Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
Estonia · Dalmevin, Glypvilo
Spain · Vildagliptina, Vildagliptina Alter
Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
France · Vildagliptine Accord, Vildagliptine Arrow
United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
Greece · Dalmevin, Varbos
Croatia · Agnis, Dalmevin
Hungary · Agartha, Alikval
Ireland · Vildagliptin Krka
Iceland · Galvus, Jalra
Italy · Vildagliptin Accord, Vildagliptin Aurobindo
Liechtenstein · Galvus, Jalra
Lithuania · Dalmevin, Glypvilo
Latvia · Dalmevin, Glypvilo
Malta · Alikval, Dalmevin
Netherlands · Vilanov, Vildagliptine Accord
Norway · Galvus, Jalra
Portugal · Tutecvi, Vezagla
Romania · Agartha, Dalmevin
Sweden · Dalmevin, Kwikaton
Slovenia · Glypvilo
Slovakia · Anvildis, Dalmevin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bc41608c-9756-47f4-be3c-7d433a073241
GET /v1/drugs/bc41608c-9756-47f4-be3c-7d433a073241?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991457549 ¦ Rp ¦ 140787\n14 tabl. w blistrze\n05909991457556 ¦ Rp ¦ 140788\n28 tabl. w blistrze\n05909991457563 ¦ Rp ¦ 140789\n30 tabl. w blistrze\n05909991457570 ¦ Rp ¦ 140790\n56 tabl. w blistrze\n05909991457587 ¦ Rp ¦ 140791\n60 tabl. w blistrze\n05909991457594 ¦ Rp ¦ 140792\n90 tabl. w blistrze\n05909991457600 ¦ Rp ¦ 140793\n105 tabl. w blistrze\n05909991457617 ¦ Rp ¦ 140794\n112 tabl. w blistrze\n05909991457624 ¦ Rp ¦ 140795\n180 tabl. w blistrze\n05909991457631 ¦ Rp ¦ 140796\n14 tabl. w blistrze perforowanym\n05909991457648 ¦ Rp ¦ 140797\n28 tabl. w blistrze perforowanym\n05909991457655 ¦ Rp ¦ 140798\n30 tabl. w blistrze perforowanym\n05909991457662 ¦ Rp ¦ 140799\n56 tabl. w blistrze perforowanym\n05909991457679 ¦ Rp ¦ 140800\n60 tabl. w blistrze perforowanym\n05909991457686 ¦ Rp ¦ 140801\n90 tabl. w blistrze perforowanym\n05909991457693 ¦ Rp ¦ 140802\n105 tabl. w blistrze perforowanym\n05909991457709 ¦ Rp ¦ 140803\n112 tabl. w blistrze perforowanym\n05909991457716 ¦ Rp ¦ 140804\n180 tabl. w blistrze perforowanym",
  "substance": "Vildagliptinum 50 mg",
  "common_name": "Vildagliptinum",
  "pl_product_id": "100416134",
  "pozwolenie_nr": "26484",
  "auth_procedure": "DCP",
  "authorisation_validity": "2026-06-29"
}

API reference MCP server Plans

See everything about vildagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console